Marija Butkovic

Hims & Hers Health, Inc., the consumer-first platform focused on providing modern, personalized health and wellness experiences to consumers, today released its first annual “Let’s Talk About Sex: The 2022 Report.”

Proov, makers of the first and only FDA-cleared PdG-test and the first full cycle tracking kit, today announces first of its kind findings that should help inform the medical community and American women surrounding the role of progesterone.

In this article, four industry experts that have committed their careers to improving healthcare outcomes for women in the cardiovascular space, are sharing their stories and predictions on what the future of female cardiovascular health could look like.

The Council, the consortium of all-female operators that’s been joining cap tables since early 2019, today announced their venture arm and its $5 million debut fund, The Council Fund.

Recognizing the impact that the beauty industry has on the planet, Treatwell, the European leader in online booking of beauty and wellness services, today announces its new three-step sustainability commitment to play its part in the fight against climate change.

Elix, the first digital platform to combine Traditional Chinese Medicine (TCM) with a proprietary algorithm, announced today the results of a pioneering clinical trial that validates the efficacy of its main product, Cycle Balance, supporting treatment of menstrual symptoms.

Featured in this story are 11 female scientists, innovators, and entrepreneurs who have made it their mission to ensure a better future for themselves and menopausal women globally, through their advocacy, education, and pushing the boundaries of what life after 50 should look like for women.

Ourspace is a purpose-built software created specifically for tech leaders to equip them to make smarter team design decisions by bringing together people, projects and priorities into one contextual place, $2.5 million in pre-seed funding, raised by Connect Ventures with participation by Seedcamp.

There are more lost disability-adjusted life years (DALYs) by women to breast cancer globally than any other type of cancer. Vara, a startup building an intelligent platform that infuses state-of-the-art AI into routine breast screenings, is on a mission to find every deadly breast cancer early.

U.K.-based gynaecological health startup Daye has completed a £10 million funding round and announced the launch of its vaginal microbiome screening tests that can detect infections and pathogens which are linked to STIs and vaginal infections, as well as fertility, pregnancy and IVF complications.

Midi Health, a virtual care clinic making expert care accessible and affordable for women experiencing the hormonal changes of midlife, today announced a $14 million seed investment funding round co-led by Felicis and SemperVirens.

WellTheory is a company on a mission to support those living with autoimmunity and, in turn, reverse the autoimmune epidemic, backed by $7.2 million seed funding round led by Accel, with participation from Box Group, Lux Capital, Scribble Ventures, Rock Health, and more.

Repro Grants is a “fast grants” program, that awards $25,000 - $100,000 to ambitious research projects aiming to deepen our understanding of the female reproductive system. Women’s health attracts only a minuscule percentage of all science funding – about 11% of all NIH funding in 2019.

Herself Health, a new healthcare technology company designed to deliver advanced primary care to women over 65, announced today its first clinic opening and closing of a $7 million seed round funding round led by founding partner Juxtapose.

With this new financing, TBD Health is expanding to all 50 states, democratizing access to its sexual healthcare offerings, consisting of at-home STD testing and emergency contraception available via telehealth or in-person in its Las Vegas Care hub.

Over the last two years, the company has expanded across the U.S. — growing from six to 34 states and covering more than 85% of women of reproductive age.

With this strategic partnership, Natural Cycles ventures into the world of wearables and hardware development.

Genecis is using specialized bacteria to convert organic waste, like bread crusts and other food scraps, into bioplastics.

Genecis is using specialized bacteria to convert organic waste, like bread crusts and other food scraps, into bioplastics.

The company aims to address the significant disparity in access to high-quality, evidence-based mental health care for younger generations.